CIK 0001783183 · Non-accelerated filer<br>Smaller reporting company
Phathom Pharmaceuticals, Inc.
Sign in to watch- Ticker
- PHAT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 824151574
- Phone
- (877) 742-8466
- Business address
- 100 CAMPUS DRIVE,, SUITE 102, FLORHAM PARK, NJ, 07932
- 8-K Event Executive or director change
- 4 Grant or award Chief Operating Officer acquired 19,500 shares (grant or award)
- 4 Grant or award VP, Chief Accounting Officer acquired 6,000 shares (grant or award)
- 4 Grant or award President and Chief Executive acquired 41,250 shares (grant or award)
- SC 13D/A Stake Beneficial Ownership Report
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale 10% owner sold 1,000,001 shares at an average $20.85 ($20,850,019)
- 424B5 Offering Prospectus
- 8-K Event Results of operations · Other events
- 4 Open-market sale Director sold 18,000 shares at an average $32.58 ($586,395)
- 8-K Event Other events
- 4 Open-market sale Director sold 18,000 shares at an average $32.63 ($587,351)
- 8-K Event Material agreement · Agreement ended · New debt or obligation · Unregistered share sale
- 8-K Event Other events
- 4 Open-market sale Director sold 18,000 shares at an average $31.25 ($562,538)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Other events
- 4 Derivatives Options or other derivatives
Page 17 of 25 · 496 filings